Release Date: January 21, 2022
Expiration Date: January 21, 2023
Overview
Myeloproliferative neoplasms (MPNs) comprise a diverse range of hematologic cancers, with optimal management requiring careful risk stratification and treatment planning. In recent years, novel therapeutic options and improved risk stratification have allowed clinicians to provide care that optimizes management of disease-related symptoms and long-term complications while minimizing the risk of serious adverse events.
This Community Practice Connections™ program provides a review of the current state of MPN management as well as key highlights from the 63rd
American Society of Hematology Annual Meeting & Exposition, held in December 2021. This unique and engaging multimedia activity is ideal for the community-based clinician and focuses on the practical aspects managing patients with MPNs including polycythemia vera (PV) and myelofibrosis (MF), putting recent clinical trial data into clinical context by combining written content with video interviews of the faculty. The program is designed for those who did not attend the live meeting and to help reinforce learning for those who did.
Target Audience
This educational program is directed toward medical oncologists, hematologists, and other health care professionals who treat patients with MPNs. Fellows, researchers, nurse practitioners, nurses, physician assistants, and other allied professionals interested in hematologic malignancies are also invited to attend.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Determine the impact of genetics, symptom burden, and risk stratification on therapy selection in MPNs
- Evaluate the clinical profiles of current and emerging therapeutic strategies in MPNs across lines of therapy
- Identify and manage disease-associated symptoms and treatment-related toxicities in patients with MPNs
- Translate updated clinical trial evidence and guidelines into personalized treatment plans for patients with MPNs to optimize care across the disease continuum
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
